We considered it necessary to implement this [shared-information certificate] tool in France, even though it is not required at the European level. The purpose of this information-acknowledgment form is to ensure that the essential information regarding the use of finasteride and its psychiatric and sexual risks has been explained to the patient and that the patient has fully understood it.
—Suicidal Risk with Hair-loss Drug Finasteride: How can patients be protected? 20 Minutes, April 17, 2026